KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient

Cited by (570)

Items 301–400 of 570

1. Ghrelin and acyl ghrelin levels are associated with inflammatory and nutritional markers and with cardiac and vascular dysfunction parameters in hemodialysis patients
   C. Rusu, S. Racasan, D. Moldovan, A. Potra, D. Tirinescu, Cristian Budurea, R. Orăşan, I. Pațiu, C. Bondor, D. Vlăduțiu et al. · 2018 · International Urology and Nephrology
2. Translational science in albuminuria: a new view ofde novoalbuminuria under chronic RAS suppression
   Montserrat Baldan Martin, Elena Rodríguez‐Sánchez, Laura Gonzalez‐Calero, Luis Miguel Ruilope, Gloria Álvarez‐Llamas, María G. Barderas, Gema Ruiz‐Hurtado · 2018 · Clinical Science
3. Chronic kidney disease: Statins in chronic kidney disease: time to move on?
   R. Haynes, C. Wanner · 2015 · Nature Reviews Nephrology
4. Screening, Diagnosis, and Management of Pediatric Hypertriglyceridemia: A Scientific Statement From the American Heart Association
   Amy Lynn Hering Peterson, Ambika P. Ashraf, Jennifer Bachman, Robert Alexander Hegele, Maya Rashad, Andrew Michael South, Andrew H. Tran, Justin P.V. Zachariah, Jonathan P. Wong · 2026 · Arteriosclerosis Thrombosis and Vascular Biology
5. Coronary artery disease and percutaneous coronary intervention in patients with severe chronic kidney disease
   Doosup Shin, Keyvan Karimi Galougahi, Mandeep Singh, Emma Caron, Matthew Cannata, Yasemin Ciftcikal, Misha Gujja, Koshiro Sakai, Jeffrey W. Moses, Richard Shlofmitz et al. · 2025 · Progress in Cardiovascular Diseases
6. Long-Term Benefits and Safety of Statins in Patients with Kidney Failure
   Franco Wing Tak Cheng, Wanchun Xu, Sydney C.W. Tang, Eric Yuk Fai Wan · 2024 · Journal of the American Society of Nephrology
7. Integrin-linked kinase mRNA expression in circulating mononuclear cells as a biomarker of kidney and vascular damage in experimental chronic kidney disease
   Sofía Campillo, Elena Gutiérrez-Calabrés, Susana García-Miranda, Mercedes Griera, Loreto Fernández Rodríguez, Sergio de Frutos, Diego Rodríguez-Puyol, Laura Calleros · 2024 · Cell Communication and Signaling
8. How Does ADPKD Severity Differ Between Family Members?
   Klement Yeung, Elise M. Fryml, Matthew Bruce Lanktree · 2024 · Kidney International Reports
9. Lipid abnormalities in pediatric kidney transplant recipients on steroid withdrawal maintenance immunosuppression
   Emily E. Zangla, Ruchi Gupta Mahajan, Ziou Jiang, Sarah J. Kizilbash · 2023 · Pediatric Nephrology
10. Total cholesterol and mortality in peritoneal dialysis: a retrospective cohort study
    Jun-Nan Wu, Rui-yun Yang, Xiao-Yang Wang, Xiao-Jiang Zhan, Yue-Qiang Wen, Xiao-Ran Feng, Nian-Song Wang, Fen-Fen Peng, G. Jian, Xian-Feng Wu · 2023 · BMC Nephrology
11. Systolic blood pressure, low-density lipoprotein cholesterol levels, and adverse kidney outcome: results from KNOW-CKD
    Kyung Won Kim, Hee Byung Koh, Hyung Woo Kim, Jung Tak Park, Tae‐Hyun Yoo, Shin‐Wook Kang, Kook‐Hwan Oh, Young Youl Hyun, Ji Yong Jung, Su Ah Sung et al. · 2023 · Hypertension Research
12. Circulating Proprotein Convertase Subtilisin/Kexin type 9 level independently predicts incident cardiovascular events and all-cause mortality in hemodialysis black Africans patients
    François Kajingulu, François Bompeka Lepira, Aliocha Natuhoyila Nkodila, Jean-Robert Rissassi Makulo, Vieux Momeme Mokoli, Pépé Mfutu Ekulu, Justine Busanga Bukabau, Yannick Mayamba Nlandu, Augustin Luzayadio Longo, Nazaire Mangani Nseka et al. · 2022 · BMC Nephrology
13. Management of long-term cardiovascular risk factors post organ transplant
    Juan Carlos de la Fuente-Mancera, Ilana Forado-Bentar, Marta Farrero · 2021 · Current Opinion in Organ Transplantation
14. The ratio of triglycerides to high-density lipoprotein cholesterol is associated with the risk of chronic kidney disease in Korean men.
    Joungyoun Kim, Yoon-Jong Bae, Sang J. Shin, Hyo-Sun You, Jae-woo Lee, Hee-Taik Kang · 2021 · Lipids
15. Management of metabolic alterations in adult kidney transplant recipients: A joint position statement of the Italian Society of Nephrology (SIN), the Italian Society for Organ Transplantation (SITO) and the Italian Diabetes Society (SID)
    Caterina Conte, Umberto Maggiore, Gianni Cappelli, Giuseppe Ietto, Quirino Lai, Paola Salis, Piero Marchetti, Lorenzo Piemonti, Antonio Secchi, Enzo Capocasale et al. · 2020 · Nutrition Metabolism and Cardiovascular Diseases
16. Dietary intake as a predictor for all-cause mortality in hemodialysis subjects (NUGE-HD study)
    K. P. Balbino, L. L. Juvanhol, Andreza de Paula Santos Epifânio, Luciane Domingos Marota, J. Bressan, H. H. Hermsdorff · 2019 · PLoS ONE
17. PROtective Ventilation with a low versus high Inspiratory Oxygen fraction (PROVIO) and its effects on postoperative pulmonary complications: protocol for a randomized controlled trial
    Xuefei Li, Dan Jiang, Yu-Lian Jiang, Hong Yu, Jia-Li Jiang, Lei-Lei He, Xiao-Yun Yang, Hai Yu · 2019 · Trials
18. Urinary Neutrophil Gelatinase-Associated Lipocalin Is Complementary to Albuminuria in Diagnosis of Early-Stage Diabetic Kidney Disease in Type 2 Diabetes
    Agnieszka Gala‐Błądzińska, Paulina Dumnicka, Beata Kuśnierz‐Cabala, Katarzyna Rybak, Ryszard Drożdż, Agnieszka Żyłka, Marek Kuźniewski · 2017 · BioMed Research International
19. Effects of Statins on Cardiovascular Outcomes in Patients With Chronic Kidney Disease
    Constantine E. Kosmas, Eddy DeJesus, Evdokia Sourla, Rosmery Morcelo, Peter D. Montan, Eliscer Guzman · 2017
20. Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins With Cyclosporine
    Donald G. Lamprecht, Brittany A. Todd, Anne M Denham, Leslie K. Ruppe, Sheila L. Stadler · 2016 · Annals of Pharmacotherapy
21. Acute Kidney Injury Treated with Dialysis outside the Intensive Care Unit: A Retrospective Observational Single-Center Study
    H. Sprenger-Mähr, E. Zitt, K. Lhotta · 2016 · PLoS ONE
22. Prescription Rates of Cardiovascular Medications in a Large UK Primary Care Chronic Kidney Disease Cohort
    Rupert Major, David J. Shepherd, Graham L. Warwick, Nigel J. Brunskill · 2016 · The Nephron journals/Nephron journals
23. Comprehensive Care for People With Diabetic Kidney Disease
    Koyal Jain, Amy K. Mottl · 2015 · Diabetes Spectrum
24. Cyclosporin A-Induced Dyslipidemia and LDL Receptors
    Maaike Kockx, Leonard Kritharides · 2018 · Elsevier eBooks
25. A Network Pharmacology-Based Investigation into the Mechanism of Quercetin Combined with Rosuvastatin in Delaying Diabetic Nephropathy via Inhibiting NRK-52E Cell Ferroptosis
    Meishe Gan, Zhi-Yuan Lin, Jun-Xue Ma, Ning Li, Biaoliang Wu · 2025 · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
26. Kidney Allograft Rejection as an Independent Nontraditional Risk Factor for Post-Transplant Cardiovascular Events
    Peemai Amornkanjanawat, Stephen J. Kerr, T. Wuttiputhanun, N. Townamchai, A. Leelahavanichkul, P. Tantiyavarong, K. Praditpornsilpa, S. Eiam-Ong, Y. Avihingsanon, S. Udomkarnjananun · 2025 · Kidney360
27. Closing CKD Treatment Gaps: Why Practice Guidelines and Better Drug Coverage Are Not Enough.
    Anukul Ghimire, C. Wanner, Marcello Tonelli · 2025 · American Journal of Kidney Diseases
28. Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy
    V. Kratky, A. Valerianova, Z. Hruskova, V. Tesař, Jan Malík · 2024 · Current Atherosclerosis Reports
29. C‐X‐C chemokine receptor type 4 promotes tubular cell senescence and renal fibrosis through β‐catenin‐inhibited fatty acid oxidation
    Qinyu Wu, Qiurong Chen, Dan Xu, Xiao-Xu Wang, Huiyun Ye, Xiao-long Li, Ya-Bing Xiong, Jie-Mei Li, Shan Zhou, Jin-Hua Miao et al. · 2024 · Journal of Cellular and Molecular Medicine
30. Comprehensive assessment of the combined impact of dyslipidemia and inflammation on chronic kidney disease development: A prospective cohort study.
    Jihyun Yoon, Tae-hwa Han, Seok-Jae Heo, Yu-Jin Kwon · 2024 · Journal of Clinical Lipidology
31. Medical Management of Coronary Artery Disease in Patients with Chronic Kidney Disease
    Jitae A. Kim, Seulgi Erica Kim, Karim El Hachem, Hafeez Ul Hassan Virk, Mahboob Alam, Salim S. Virani, Samin Kumar Sharma, Andrew A. House, Chayakrit Krittanawong · 2023 · The American Journal of Medicine
32. Factors associated with changes in echocardiographic parameters following kidney transplantation
    Q. d'Herve, N. Girerd, E. Bozec, Z. Lamiral, V. Panisset, L. Frimat, O. Huttin, S. Girerd · 2023 · Clinical Research in Cardiology
33. Trajectory of low-density lipoprotein cholesterol in patients with chronic kidney disease and its association with cardiovascular disease
    Shih-Wei Wang, Lung-Chih Li, Chung-Ming Fu, Yueh-Ting Lee, H. Kuo, Chien-Ning Hsu · 2022 · Frontiers in Cardiovascular Medicine
34. Diabetes mellitus y riesgo cardiovascular: actualización de las recomendaciones del Grupo de Trabajo de Diabetes y Enfermedad Cardiovascular de la Sociedad Española de Diabetes (SED, 2021)
    Francisco Arrieta, Juan Pedro‐Botet, Pedro Iglesias, Juan Carlos Obaya, Laura Montánez, Gonzálo Fernando Maldonado, Antonio Becerra, Jorge Navarro, J.C. Perez, Romina Petrecca et al. · 2021 · Clínica e Investigación en Arteriosclerosis
35. Non‐HDL cholesterol is an independent predictor of long‐term cardiovascular events in patients with dyslipidemia after renal transplantation
    Umut Karabulut, Ülkem Çakır · 2021 · International journal of clinical practice
36. Statin use and incident cardiovascular events in renal transplant recipients
    Josephine L.C. Anderson, Markus van der Giet, Antonio W. Gomes Neto, Stephan J. L. Bakker, Uwe J.F. Tietge · 2021 · European Journal of Clinical Investigation
37. Effects of Statins on Lipid Profile of Kidney Transplant Recipients: A Meta-Analysis of Randomized Controlled Trials
    Xiu Huang, Yong Jia, Xiao-Yu Zhu, Yang-Yang Zhang, Lili Jiang, Xue-Jiao Wei, Dan Zhao, Xiao-Xia Zhao, Yu-Jun Du · 2020 · medRxiv
38. Schimke immunoosseous dysplasia and management considerations for vascular risks
    Daniah T. Beleford, Mohammad Diab, William F. Qubty, Mary J. Malloy, Roger K. Long, Joseph T.C. Shieh · 2019 · American Journal of Medical Genetics Part A
39. Attainment of Guideline-Directed Medical Treatment in Stable Ischemic Heart Disease Patients With and Without Chronic Kidney Disease
    E. Koutroumpakis, Elvira O. Gosmanova, Heather Stahura, S. Jou, Rabah Alreshq, A. Ata, M. Sidhu, E. Philbin, W. Boden, R. Lyubarova · 2019 · Cardiovascular Drugs and Therapy
40. Precision Medicine and Personalized Management of Lipoprotein and Lipid Disorders in Chronic and End-Stage Kidney Disease
    Elani Streja, Dan A. Streja, Melissa Soohoo, Carola‐Ellen Kleine, Jui‐Ting Hsiung, Christina Park, Hamid Moradi · 2018 · Seminars in Nephrology
41. Nitroglycerin mediated dilation evaluated by ultrasound is associated with sTWEAK in hemodialysis patients.
    C. Rusu, L. Ghervan, S. Racasan, I. Kacsa, D. Moldovan, A. Potra, C. Bondor, F. Anton, I. Pațiu, M. Căprioară · 2016 · Medical ultrasonography
42. Prevention of Heart Failure in Patients with Chronic Kidney Disease
    Amr Raghban, Jennifer Kirsop, W.H. Wilson Tang · 2014 · Current Cardiovascular Risk Reports
43. Guías de práctica clínica de manejo de la dislipemia en diabéticos y otros grupos de riesgo
    Marta Fanlo‐Maresma, Xavier Pintó · 2015 · Revista Española de Cardiología Suplementos
44. Diabetic kidney disease, biomarkers, and finerenone
    Ashish Verma, Ashish Upadhyay · 2026 · Diabetes Obesity and Metabolism
45. Independent and Combined Impacts of Obesity and Aging on Chronic Kidney Disease
    Yao Ma, Chi Xu, Yuanli Shen, Yandi Cheng, Weihong Zhao · 2025 · Obesity Reviews
46. Statins and kidney health: exploring cardiovascular benefits, renal protection, and risks in chronic kidney disease
    Rahul Chikatimalla, Y. Trivedi, N. Ruhela, Shubhangi Singh, Amar Lal, Akhil Pawa, Baltej Singh, Rohit Jain · 2025 · Postgraduate medicine
47. Male and female drug prescription patterns and adverse drug reactions in chronic kidney disease
    Solène M. Laville, Agathe Mouheb, Ziad A. Massy, Christian Jacquelinet, Maurice Laville, Bénédicte Stengel, Natália Alencar de Pinho, Sophie Liabeuf, the CKD-REIN study collaborators, Natalia Alencar de Pinho et al. · 2025 · Nephrology Dialysis Transplantation
48. Cholesterol and Cardiovascular Risk in Type 2 Diabetes: The Role of Kidney Function
    Ji-Hyun Kim, Seung-Hwan Lee, Kyu Na Lee, Kyung-do Han, M. Kim · 2025 · Journal of Lipid and Atherosclerosis
49. Lipid-lowering drugs and risk of rapid renal function decline: a mendelian randomization study
    Zhi-Cheng Zhao, Y. Wan, Han Fu, Shuo Ying, Peng Zhang, Hao-Yu Meng, Yu Song, N. Fu · 2024 · BMC Medical Genomics
50. Lipid Management in Kidney Transplant Recipients Per KDIGO and American Heart Association Guidelines: A Single-Center Experience
    Ziad Arabi, Mohammed H. Tawhari, Abdullah A. A. AlGhamdi, Ahmad Alnasrullah · 2024 · Saudi Journal of Medicine and Medical Sciences
51. Proteomic insights into the pathophysiology of hypertension-associated albuminuria: Pilot study in a South African cohort
    M. Govender, S. Stoychev, Jean-Tristan Brandenburg, M. Ramsay, J. Fabian, Ireshyn S Govender · 2023 · bioRxiv
52. Oxidative stress as the bridge between dyslipidemia and peritoneal ultrafiltration failure: A bi-center cross-sectional cohort study
    N. Stepanova, L. Korol, O. Burdeyna, L. Snisar, A. Rysyev, V. Filonov, I. Poperechny · 2023 · Ukrainian Journal of Nephrology and Dialysis
53. The prevalence of dyslipidemia in patients on hemodialysis: a cross-sectional study from Syria
    Yasmeen Hasan, Mohammad Khaled Alsultan, Mohamed Taher Anan, Qussai Hassn, Kassem Basha · 2023 · Annals of Medicine and Surgery
54. Prognostic role of neutrophil gelatinase-associated lipocalin in patients with coronary artery disease and abdominal obesity
    A. Svarovskaya, P. Astanin, A. Teplyakov, A. D. Vende, O. Ogurkova, A. Garganeeva · 2023 · Russian Journal of Cardiology
55. Factors associated with incidence of acute kidney injury: a Japanese regional population-based cohort study, the Shizuoka study
    Hisashi Dote, E. Nakatani, Kiyoshi Mori, Akira Sugawara · 2022 · Clinical and Experimental Nephrology
56. Statin uses in adults with non-dialysis advanced chronic kidney disease: Focus on clinical outcomes of infectious and cardiovascular diseases
    Ching-Chung Hsiao, Jih-Kai Yeh, Yan-Rong Li, Wei-Chiao Sun, P. Fan, C. Yen, Jung-Sheng Chen, Chih-Hung Lin, Kuan-Hsing Chen · 2022 · Frontiers in Pharmacology
57. Treatment of Mixed Dyslipidemia With Alirocumab in a Kidney Transplant Recipient: A Case Report.
    M. Papasotiriou, T. Ntrinias, E. Savvidaki, E. Papachristou, D. Goumenos · 2021 · Transplantation Proceedings
58. Rosuvastatin Failed to Improve Arteriovenous Fistula Patency for Hemodialysis in Diabetic Patients - A Randomized Clinical Trial.
    Jun‐Neng Roan, Wei‐Hung Lin, Meng Ta Tsai, Te Hui Kuo, Ting Wei Lin, Di Yung Chen, Shih‐Yuan Fang, Ya Ping Hsieh, Chung‐Yi Li, Chen Fuh Lam · 2021 · Europe PMC (PubMed Central)
59. Successful sirolimus therapy of an aplastic anemia patient with chronic kidney disease
    Haiyue Niu, Wei-Wei Qi, Yi-Hao Wang, Li-Min Xing, R. Fu, Z. Shao, Hua-Quan Wang · 2020 · Medicine
60. Alirocumab in a high cardiovascular risk patient on hemodialysis with liver abnormalities
    Periklis Dousdampanis, Stelios F. Assimakopoulos, Ioulia Syrocosta, Ioannis G. Ntouvas, Kostas Gkouias, Konstantina Trigka · 2020 · Hemodialysis International
61. Kardiovaskuläre Pharmakotherapie und koronare Revaskularisation bei terminaler Niereninsuffizienz
    Lucas Lauder, Sebastian Ewen, Insa E. Emrich, Michael Böhm, Felix Mahfoud · 2019 · Herz
62. Treatment of Central Nervous System Complications of Renal Dialysis and Transplantation
    S. Dahdaleh, P. Malhotra · 2019 · Current Treatment Options in Neurology
63. Dyslipidemia
    Harvey A. Feldman, Kim Zuber, Jane S. Davis · 2017 · Physician Assistant Clinics
64. Eligibility for Statin Treatment in Korean Subjects with Reduced Renal Function: An Observational Study
    B. Moon, Jongho Kim, Ji Hyun Kim, Y. Hyun, Se Eun Park, H. Oh, Cheol-Young Park, Won-Young Lee, K. Oh, Kyu-Beck Lee et al. · 2016 · Endocrinology and Metabolism
65. Dyslipidemias and chronic kidney disease: a focus on pathogenesis and treatment
    Stefano DE VUONO, Maria A Ricci, Massimo Raffaele Mannarino, Graziana Lupattelli · 2014 · Clinical Lipidology
66. Atorvastatin in combination with ezetimibe and carotid atherosclerosis.
    K. Paraskevas, D. Mikhailidis, A. Giannoukas · 2014 · Genetics and Molecular Research
67. Complexity and Management of Chronic Kidney Disease
    Pranali M. Wandile · 2023 · Open Journal of Nephrology
68. Más allá de los parámetros lipídicos tradicionales en la enfermedad renal crónica
    Marcelino Bermúdez-López, Àngels Betriu, José Manuel Valdivielso, Teresa Bretones del Pino, David Arroyo, Elvira Fernández · 2017 · Nefrología
69. Lipid lowering therapies in chronic kidney disease: A call to action
    Jaime Mazón Ruiz, David Arroyo, Marina de Cos, María Riestra Fernández, Emilio Sánchez-Álvarez, Paula González Bores, José L. Hernández, Pablo Corral · 2025 · Atherosclerosis
70. Effect of Statins in Patients With Hemodialysis‐Dependent Chronic Kidney Disease: A Nationwide Cohort Study
    Minyoul Baik, Jimin Jeon, Joonsang Yoo, Jinkwon Kim · 2025 · Journal of the American Heart Association
71. Association between the triglyceride to high-density lipoprotein cholesterol ratio and diabetes mellitus likelihood in patients with chronic kidney disease
    Mijie Guan, Shuang Cui, Haiying Song, Haofei Hu, Bo Hu · 2025 · BMC Nephrology
72. Transition of Care of Kidney Recipients from Transplant Centers to Referring Nephrologists: Report from the American Society of Transplantation Controversies Conference.
    P. Anand, Neeraj Singh, Gaurav Gupta, Mona D. Doshi, B. Tanriover, D. Adey, K. L. Lentine, S. Niederhaus, Ronald F. Parsons, Alexander Wiseman et al. · 2025 · American Journal of Kidney Diseases
73. Potential Health Benefits of Dietary Tree Nut and Peanut Enrichment in Kidney Transplant Recipients—An In-Depth Narrative Review and Considerations for Future Research
    Daan Kremer, Fabian A. Vogelpohl, Yvonne van der Veen, Caecilia S E Doorenbos, Manuela Yepes-Calderón, Tim J. Knobbe, Adrian Post, Eva Corpeleijn, Gerjan Navis, Stefan P. Berger et al. · 2025 · Nutrients
74. Evaluation of Statins Use in Hemodialysis Patients: A Retrospective Analysis of Clinical and Safety Outcomes
    Abdulmalik S. Alotaibi, Mohamed A. Albekery, Ahmed A. Alanazi, Ibrahim S. Alhomoud, Khalid A. Alamer, Mohammad S Shawaqfeh, Reem Salem Alshammari, Fayez F. Alhejaili, Muthana A. Al Sahlawi, Ibrahim Aldossary et al. · 2025 · Pharmaceuticals
75. Implementation of Pharmacist Case-Finding and Care Pathway Intervention for Vascular Prevention (PRxOACT): Protocol for a Randomized Controlled Trial
    Shania Liu, Ross T. Tsuyuki, Michelle M. Graham, D. Nelson, G. Semeniuk, Y. A. Al Hamarneh · 2025 · CJC Open
76. Correlation between thromboembolic risk and prevalence of coronary artery disease in patients with atrial fibrillation and impaired renal function
    T. Murakami, A. Yagishita, K. Ayabe, Susumu Sakama, Kyong Hee Lee, M. Amino, K. Yoshioka, Y. Ikari · 2024 · International Journal of Cardiology: Heart & Vasculature
77. Comorbidity and Medication Trends in Chronic Kidney Disease and Incident Atrial Fibrillation: A Nationwide Cohort Study
    Heini Jyrkilä, Kati Kaartinen, Leena Martola, Olli Halminen, Jari K. Haukka, Miika Linna, Pirjo E. Mustonen, Jukka Putaala, Konsta Teppo, Janne Kinnunen et al. · 2024 · The Nephron journals/Nephron journals
78. Update sulla malattia renale diabetica (DKD): focus sulla DKD non albuminurica e il rischio cardiovascolare
    Direzione Scientifica, Sebastiano Squatrito, Catania Direttore, Responsabile Stefano Melloni, Maurizio Sabrina Scilletta, D. Marco, Nicoletta Miano, Agnese Filippello, S. Di Mauro, A. Scamporrino et al. · 2024 · il Diabete
79. Serum apolipoproteins (apoA-1, apoB, and apoB/apoA-1 ratio) for early identification of dyslipidemia in children with CKD
    Akshay Kumar M, Mukta Mantan, Bhawna Mahajan · 2023 · Pediatric Nephrology
80. Safety and incremental prognostic value of stress cardiovascular magnetic resonance in patients with known chronic kidney disease
    T. Pezel, T. Unterseeh, T. Hovasse, F. Sanguineti, P. Garot, S. Champagne, S. Toupin, T. Ah-Sing, A. Faradji, M. Nicol et al. · 2023 · Journal of Cardiovascular Magnetic Resonance
81. Invasive Management and Outcomes in Acute Coronary Syndromes and Chronic Kidney Disease (ANZACS-QI 70)
    Andrew Kerr, Yeunhyang Catherine Choi, Helen Pilmore · 2023 · Heart Lung and Circulation
82. Prevention of Cardiovascular Events in Patients With Chronic Kidney Disease
    Chris M. Terpening · 2023 · Annals of Pharmacotherapy
83. Long-term visit-to-visit variability in low-density lipoprotein cholesterol is associated with poor cardiovascular and kidney outcomes in patients with primary nephrotic syndrome
    Xuan Lai, Z. Cui, Hua Zhang, Yi-miao Zhang, Fang Wang, Xin Wang, Li-qiang Meng, Xu-yang Cheng, Gang Liu, Ming-Hui Zhao · 2023 · International Urology and Nephrology
84. Use of Statins in Kidney Transplant Recipients in Norway
    M. Rønning, V. Hjellvik, Solveig Sakshaug, H. Blix, K. Midtvedt, A. Reisæter, H. Holdaas, A. Åsberg · 2022 · International Journal of Environmental Research and Public Health
85. Pronóstico de pacientes nonagenarios ingresados por fracaso renal agudo
    B. Quiroga, M. Sanz, P. Ramos, B. Santos, N. Gilabert, S. Otero, P. Carles, R. Costa, L. Mayor, P. Ruano · 2021 · Anales del Sistema Sanitario de Navarra
86. Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non‐dialysis CKD: An observational study
    Insa E. Emrich, Gunnar Henrik Heine, Paul Christian Schulze, Kyrill Sebastian Rogacev, Danilo Fliser, Stefan Wagenpfeil, Michael Böhm, Dieter Lütjohann, Oliver Weingärtner · 2021 · Pharmacology Research & Perspectives
87. Triglyceride/HDL cholesterol ratio and premature all-cause mortality in renal transplant recipients.
    Josephine L. C. Anderson, S. Bakker, U. Tietge · 2020 · Nephrology, Dialysis and Transplantation
88. LDL-cholesterol reduction in chronic kidney disease: options beyond statins
    Michelle Abhayawardena Goonasekera, Marion M. Mafham, Richard Haynes · 2020 · Current Opinion in Nephrology & Hypertension
89. Chronische Nierenerkrankung – eine kardiovaskuläre Höchstrisikokonstellation
    Thimoteus Speer, Stefan J. Schunk, Danilo Fliser · 2019 · Der Internist
90. Nefroangioesclerosis
    B. Quiroga, D. Arroyo, G. D. Arriba de la Fuente · 2019 · Medicine - Programa de Formación Médica Continuada Acreditado
91. Cardiovascular disease in kidney transplant recipients: leave no stone unturned
    Steven Van Laecke, Daniel Abramowicz · 2019 · Nephrology Dialysis Transplantation
92. 2016 Guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacists
    Ricky D. Turgeon, Todd J. Anderson, Jean Grégoire, Glen J. Pearson · 2017 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
93. Framing and managing cardiovascular risk in chronic kidney disease: from native to transplanted kidney
    E. Dounousi, A. Duni, S. Marinaki, J. Boletis · 2017 · Continuing Cardiology Education
94. Diabetes-Related Microvascular Complications: What Every Nurse Practitioner Needs to Know
    Eileen A. Egan · 2017 · The Journal for Nurse Practitioners
95. Determinant Effects of Average Fasting Plasma Glucose on Mortality in Diabetic End-Stage Renal Disease Patients on Maintenance Hemodialysis
    Yi-Chun Lin, Yen-Chung Lin, Hsi-Hsien Chen, T. Chen, Chih-Cheng Hsu, Mai-Szu Wu · 2016 · Kidney International Reports
96. Diabetische Nierenerkrankung (Update 2026)
    Harald Sourij, Felix Aberer, Marlies Antlanger, Johanna Brix, Daniel Cejka, Martin Clodi, Roland Edlinger, Kathrin Eller, Sabine Horn, Susanne Kaser et al. · 2016 · Wiener klinische Wochenschrift
97. Chronic Kidney Disease (Not) on the Agenda.
    K. Eckardt · 2016 · Deutsches Ärzteblatt International
98. Clinical lipidology: A subspecialty whose time has come
    Carl E. Orringer, Harold Edward Bays, William Virgil Brown · 2015 · Journal of clinical lipidology
99. Thyroid function modifies the association between ratio of triglyceride to high-density lipoprotein cholesterol and renal function: a multicenter cross-sectional study
    Zhongshang Yuan, Meng Zhao, Bingchang Zhang, Haiqing Zhang, Xu Zhang, Qingbo Guan, Guang Ning, Ling Gao, Fuzhong Xue, Jiajun Zhao · 2015 · Scientific Reports
100. Progression of Chronic Kidney Disease and Nephroprotection in Children
     Elke Wühl, H. William Schnaper · 2021 · Springer eBooks